Consistent with the phenotype in the HFD model, the knockdown of USP14 alleviated HFHC diet-induced glucose intolerance and reduced liver weight, lipid composition, and liver injury-associated enzyme activities (Fig. S3D–I). Here, USP14 is linked to Glucose intolerance.